common cold - Nursing Case Study

Pathophysiology

• Primary mechanism: Rhinoviruses, the most common causative agents, invade the upper respiratory tract, primarily targeting nasal epithelial cells, leading to cell damage and the release of pro-inflammatory mediators.

• Secondary mechanism: The inflammatory response causes vasodilation and increased vascular permeability in nasal mucosa, resulting in symptoms such as congestion, rhinorrhea, and sneezing.

• Key complication: In some cases, the viral infection can lead to a secondary bacterial infection, particularly in the sinuses or middle ear, exacerbating symptoms and prolonging recovery.

Patient Profile

Demographics:

34-year-old female, elementary school teacher

History:

• Key past medical history: Asthma diagnosed at age 10, seasonal allergic rhinitis

• Current medications: Fluticasone nasal spray, Albuterol inhaler as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Worsening cough and nasal congestion over the past week

• Key symptoms: Sore throat, headache, mild fever, persistent cough producing yellowish mucus, fatigue, and ear discomfort

• Vital signs: Temperature 100.4°F (38°C), Heart rate 92 bpm, Respiratory rate 20 breaths/min, Blood pressure 118/76 mmHg, Oxygen saturation 94% on room air

Section 1

New Complications:

Over the next few days, the patient's symptoms persisted despite her use of over-the-counter cold remedies and rest. During a follow-up visit to the clinic, additional assessments were made due to her increasing ear discomfort and persistent cough. Upon examination, the nurse noted that the patient's right tympanic membrane appeared erythematous and bulging, indicating possible acute otitis media, a common bacterial complication of viral upper respiratory infections. Her nasal congestion had not improved, and she reported increased pressure and pain over her forehead and cheeks, suggesting sinusitis. These findings prompted further evaluation and consideration of secondary bacterial infection.

A decision was made to perform a complete blood count (CBC) and a sinus X-ray to confirm the presence of a bacterial infection. The CBC results showed an elevated white blood cell count of 14,000/mm³, with a left shift indicating a bacterial process. The sinus X-ray revealed opacification in the maxillary sinuses, consistent with sinusitis. Based on these results, the clinical team diagnosed the patient with bacterial sinusitis and acute otitis media, likely secondary to her initial viral infection. Given her penicillin allergy, the team considered prescribing a suitable alternative antibiotic, such as azithromycin, to address the bacterial component of her illness.

This development in the patient's condition required careful clinical reasoning to manage the complications effectively. The team needed to monitor her response to the antibiotic therapy closely, ensuring that her asthma remained controlled and that she did not develop any further respiratory complications. The patient's teaching plan was updated to include information on recognizing signs of potential antibiotic side effects and the importance of completing the prescribed course to prevent antibiotic resistance. This phase of her care set the stage for evaluating her response to treatment and planning further interventions if necessary.

Section 2

As the patient commenced her azithromycin treatment, the healthcare team closely monitored her clinical status for any signs of improvement or further complications. Three days into the antibiotic regimen, the patient returned to the clinic with new concerns. She reported a noticeable reduction in ear pain and nasal congestion, but her cough had worsened and was now productive, with yellow-green sputum. Additionally, she experienced mild dyspnea, raising concerns about her asthma management.

During the assessment, the nurse observed that the patient appeared mildly tachypneic, with a respiratory rate of 22 breaths per minute. Auscultation of the lungs revealed wheezing in the bilateral lower lobes, a change from previous assessments, suggesting an exacerbation of her asthma likely triggered by the ongoing respiratory infection. Her vital signs were otherwise stable, with a blood pressure of 118/76 mmHg, heart rate of 88 beats per minute, and an oxygen saturation of 94% on room air. Given these findings, the clinical reasoning process focused on evaluating the need for additional interventions to prevent further respiratory compromise.

The team decided to initiate a short course of oral corticosteroids to manage the asthma exacerbation and recommended the continuation of her current asthma maintenance inhalers. They also encouraged the patient to increase her fluid intake and use a humidifier to help thin her respiratory secretions. The healthcare team reinforced the importance of adherence to her asthma action plan and educated her on recognizing early warning signs of worsening asthma. This proactive approach aimed to stabilize her respiratory status while continuing to address the bacterial complications of her initial viral infection. The patient's progress would be re-evaluated in a follow-up visit scheduled for the next week, allowing the team to assess her response to these new interventions and adjust her care plan accordingly.

Section 3

A week later, the patient returned for her follow-up visit. She reported some improvement in her breathing following the initiation of oral corticosteroids, with a slight reduction in wheezing and dyspnea. However, she noted persistent productive cough with yellow-green sputum, and a new symptom had emerged: low-grade fever, which had been fluctuating around 100.4°F (38°C) over the past two days. These symptoms raised concerns about the possibility of a secondary bacterial infection or inadequate response to the current antibiotic regimen.

During the assessment, the nurse observed that the patient's respiratory rate had decreased to 20 breaths per minute, and oxygen saturation had improved to 96% on room air. However, auscultation continued to reveal bilateral wheezing, and crackles were now present in the right lower lobe, suggesting potential consolidation. Given these findings, the healthcare team considered the need for further diagnostic evaluation. A chest X-ray was ordered, which revealed an infiltrate in the right lower lobe, consistent with a possible developing pneumonia.

The healthcare team decided to adjust the patient's antibiotic therapy, transitioning from azithromycin to a broader-spectrum antibiotic to target possible resistant pathogens. Additionally, they reviewed the patient's asthma action plan, ensuring she had adequate rescue inhalers and was educated on their proper use. The team also emphasized the importance of rest and hydration to support her recovery. With these adjustments, the patient was scheduled for another follow-up in three days to closely monitor her response to the new treatment strategy and to prevent any further complications in her respiratory status.

Section 4

Three days later, the patient returned for her follow-up appointment, and the healthcare team noted several changes in her status. The patient reported a slight improvement in her breathing; however, the productive cough persisted, with the sputum remaining yellow-green. She also continued to experience fluctuations in her low-grade fever, now ranging from 100°F to 101°F (37.8°C to 38.3°C). Upon examination, her respiratory rate was steady at 18 breaths per minute, and oxygen saturation remained at 96% on room air. However, the crackles in the right lower lobe persisted, and the wheezing was still evident bilaterally. The patient also reported increased fatigue and mild pleuritic chest pain when taking deep breaths.

In light of these findings, the healthcare team ordered follow-up diagnostic tests, including a complete blood count (CBC) and sputum culture, to further investigate the underlying cause of her symptoms. The CBC revealed leukocytosis with a white blood cell count of 15,000/mm³, indicating a continuing inflammatory or infectious process. The sputum culture, still pending, was crucial in identifying any resistant bacteria that might be contributing to the pneumonia. The team also considered the possibility of atypical pneumonia or the presence of other underlying conditions that could be complicating her recovery.

The patient's response to the adjusted antibiotic regimen was closely monitored, and additional supportive measures were implemented. The healthcare team emphasized the importance of adhering to the prescribed medication schedule and maintaining adequate hydration to aid in the clearance of secretions. The patient's asthma action plan was revisited to ensure optimal control of her chronic respiratory condition alongside the acute infection. The team scheduled another follow-up in five days to evaluate her progress, addressing any ongoing issues and considering further modifications to her treatment plan if necessary. This approach aimed to prevent any escalation of her condition while promoting a steady recovery trajectory.

Section 5

Five days later, during the follow-up appointment, the healthcare team noted significant changes in the patient's status. Her breathing had slightly improved, but she still experienced a persistent productive cough with yellow-green sputum. The patient reported new onset of night sweats and an increase in pleuritic chest pain, now more pronounced on deep inspiration. Her low-grade fever persisted, fluctuating between 100°F and 101.5°F (37.8°C to 38.6°C). Upon examination, her respiratory rate had increased to 22 breaths per minute, and oxygen saturation had decreased slightly to 94% on room air. The crackles in the right lower lobe were more pronounced, and wheezing continued bilaterally. Additionally, she exhibited mild tachycardia with a heart rate of 102 bpm.

The results of the sputum culture, now available, revealed the presence of methicillin-resistant Staphylococcus aureus (MRSA), suggesting a resistant bacterial infection complicating the initial diagnosis of pneumonia. This finding necessitated an immediate alteration in her antibiotic regimen to include a more targeted therapy against MRSA. The healthcare team also considered the possibility of empyema or lung abscess, given the patient's increased chest pain and persistent symptoms. A chest X-ray was ordered to evaluate for any pleural effusion or other complications.

In response to these developments, the healthcare team intensified their management plan. The patient was started on intravenous vancomycin to address the MRSA infection, and her asthma management was adjusted to include a short course of oral corticosteroids to reduce inflammation and improve breathing. The team provided education on recognizing warning signs of worsening respiratory status and reinforced the importance of medication adherence and follow-up care. With the new interventions in place, the team planned a re-evaluation in three days to assess the effectiveness of the treatment modifications and to monitor for any additional complications.